Skip to main content
SpringerLink
Log in

Formulation and Preliminary in vivo Testing of Rufloxacin-Cyclodextrin Ophthalmic Solutions

  • Published:
Journal of inclusion phenomena and macrocyclic chemistry Aims and scope Submit manuscript

Abstract

Aim of the present work was to investigate the effect of somecyclodextrins (CDs) on the solubility and ocular bioavailability of rufloxacin base (RUF), with theultimate goal of developing an ophthalmic formulation. Phase solubility studies of RUF inpH 7.4 buffer were carried out in the presence of β-cyclodextrin (β-CD),hydroxypropyl-β-cyclodextrin (HP-β-CD) and γ-cyclodextrin(γ-CD). The effect of hydroxypropyl methylcellulose (HPMC) on RUF solubility was evaluated after heating the solutionscontaining HP-β-CD at 120 °C.

A significant enhancement of RUF solubility was achieved by associatingthe drug with CDs, particularly HP-β-CD. This CD formed with RUF a less stablecomplex than that formed by β-CD, but did not suffer the solubility limitations ofthe parent CD, and showed a higher solubilizing capacity than γ-CD. Addition of 0.25%(w/v) HPMC to solutions containing HP-β-CD increased the solubilizing effect of this CD,thus allowing reduction of the amount necessary for solubilization of 0.3% (w/v) RUF.

Preliminary pharmacokinetic data in rabbits indicated that theocular bioavailability of 0.3% (w/v) RUF solubilized by HP-β-CD was higher when compared witha 0.3% (w/v) RUF suspension used as reference.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R. Mattina, G. Bonfiglio, C.E. Cocuzza, G. Gulisano, M. Cesana, and B.P. Imbimbo: Chemotherapy 37, 389 (1991).

    Google Scholar 

  2. P.Y. Robert and J.P. Adenis: Drugs 61, 175 (2001).

    Google Scholar 

  3. T. Loftsson and M.E. Brewster: J. Pharm. Sci. 85, 1017 (1996).

    Google Scholar 

  4. K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 98, 2045 (1998).

    Google Scholar 

  5. T. Loftsson and T. Järvinen: Adv. Drug Deliv. Rev. 36, 59 (1999).

    Google Scholar 

  6. T. Loftsson, H. Fridriksdó ttir, A.M. Sigurdardó ttir, and H. Ueda: Int. J. Pharm. 110, 169 (1994).

    Google Scholar 

  7. P. Saarinen-Savolainen, T. Järvinen, K. Araki-Sasaki, H. Watanabe, and A. Urtti: Pharm. Res. 15, 1275 (1998).

    Google Scholar 

  8. T. Higuchi and K.A. Connors: Adv. Anal. Chem. Instrum. 4, 117 (1965).

    Google Scholar 

  9. R. Beck, J. Keyserlingk, U. Fisher, R. Guthoff, and B. Drewelow: Graefe's Arch. Clin. Exp. Ophthalmol. 237, 89 (1999).

    Google Scholar 

  10. B. Cappello, C. Carmignani, M. Iervolino, M.I. La Rotonda, and M.F. Saettone: Int. J. Pharm. 213, 75 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Chimica Bioorganica e Biofarmacia, Universitá degli Studi di Pisa, Via Bonanno 33, 56126, Pisa, Italy

    Patrizia Chetoni, Susi Burgalassi & M. Fabrizio Saettone

Authors
  1. Brunella Cappello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Iervolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnese Miro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizia Chetoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susi Burgalassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Fabrizio Saettone
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cappello, B., Iervolino, M., Miro, A. et al. Formulation and Preliminary in vivo Testing of Rufloxacin-Cyclodextrin Ophthalmic Solutions. Journal of Inclusion Phenomena 44, 173–176 (2002). https://doi.org/10.1023/A:1023050814697

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023050814697

Search

Navigation